Learn about the revolutionary neoantigen therapies and mRNA vaccines transforming cancer treatment by harnessing the body's ...

In a study published in Nature Nanotechnology, researchers discovered that cuproptosis may serve as a new target for ...

Phosplatin Therapeutics is harnessing immunogenic cell death (ICD) as an alternative mechanism to existing cancer immunotherapy strategies. PT-112, Phosplatin’s lead ICD inducer, is in phase 2 ...

Researchers from Bulgaria conduct an analysis of the potential for therapeutic vaccines in by comparing testing results for ...

Therefore, it is desirable to perform more extensive histocompatibility testing for the most immunogenic organs, but the length of cold ischemia time an organ will tolerate limits the extent of ...

Announcing a new article publication for Zoonoses journal. Leishmaniases are transmitted by the protozoan parasite Leishmania through the bites of infected sandflies. Despite the availability of ...

In a study published in Nature Nanotechnology, Prof. GU Zhanjun from the Institute of High Energy Physics of the Chinese Academy of Sciences, in ...

Derived from the Latin adjuvare (to help or aid), adjuvants enhance antigen-specific vaccine immunogenicity. Added only when ...

Due to the remarkable success of the Research Topic 'New Insights in Veterinary Cancer Immunology' and the rapidly evolving subject area, we are pleased to launch Volume II for this topic. The tumour ...

Rising Pharmaceuticals, Inc. announces commercial availability of Edetate calcium disodium injection in the United States ...